Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hemant Surgical IndustriesBOM:543916 +0.38%77 PB Ratio is 3.51 as of Aug. 29, 2026, which is 4% below its 10-year median of 3.65. GuruFocus rates BOM:543916 with a GF Score™ of 77/100 and a GF Value™ of ₹338.27 (Fairly Valued). The stock has 3 warning signs investors should review. Among 783 Medical Devices & Instruments companies, Hemant Surgical Industries ranks worse than 69.35% on this metric.
The historical rank and industry rank for Hemant Surgical Industries's PB Ratio or its related term are showing as below:
BOM:543916'
s PB Ratio Range Over the Past 10 Years
Min: 1.53 Med: 3.65 Max: 10.97
Current: 3.51
During the past 6 years, Hemant Surgical Industries's highest PB Ratio was 10.97. The lowest was 1.53. And the median was 3.65.
BOM:543916's PB Ratio is ranked worse than 69.35% of 783
companies
in the Medical Devices & Instruments industry
Industry Median: 2.16
vs BOM:543916: 3.51
During the past 12 months, Hemant Surgical Industries's average Book Value Per Share Growth Rate was 74.50% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was 67.70% per year.
During the past 5 years, the average Book Value Per Share Growth Rate was 65.70% per year.
During the past 6 years, the highest 3-Year average Book Value Per Share Growth Rate of Hemant Surgical Industries was 77.70% per year. The lowest was 67.70% per year. And the median was 68.70% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Hemant Surgical Industries PB Ratio Related Terms
Hemant Surgical Industries PB Ratio Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Hemant Surgical Industries's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hemant Surgical Industries PB Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Hemant Surgical Industries's PB Ratio distribution charts can be found below:
* The bar in red indicates where Hemant Surgical Industries's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Hemant Surgical Industries (BOM:543916) has a PB Ratio of 3.51 as of Aug. 29, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hemant Surgical Industries and its competitors. This is near median its historical median of 3.65. Over the past decade, Hemant Surgical Industries' PB Ratio has ranged from 1.53 to 10.97. According to the industry distribution chart, Hemant Surgical Industries ranks #543 out of 783 companies in the Medical Devices & Instruments industry, placing it in the top 69.3%.
Is Hemant Surgical Industries' PB Ratio too high?
Hemant Surgical Industries' current PB Ratio of 3.51 is near median its 10-year median of 3.65. Over the past 10 years, this metric has ranged from a low of 1.53 to a high of 10.97. The Medical Devices & Instruments industry median PB Ratio is 2.16. Hemant Surgical Industries' value of 3.51 is 62.5% above this industry median. Based on the distribution chart, Hemant Surgical Industries ranks #543 out of 783 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Hemant Surgical Industries has a GF Score™ of 77/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hemant Surgical Industries' PB Ratio compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Hemant Surgical Industries ranks #543 out of 783 companies for PB Ratio. This places Hemant Surgical Industries in the lower half of its industry. The industry median PB Ratio is 2.16. Hemant Surgical Industries' value of 3.51 is 62.5% above this benchmark. Historically, Hemant Surgical Industries' own PB Ratio has ranged from 1.53 to 10.97 over the past decade. While the company's 10-year median is 3.65 vs. the industry median of 2.16, Hemant Surgical Industries has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Medical Devices & Instruments company?
The median PB Ratio among Medical Devices & Instruments companies is 2.16, based on 783 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hemant Surgical Industries's current PB Ratio of 3.51 is 62.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Hemant Surgical Industries and its competitors. For the Medical Devices & Instruments industry, the median PB Ratio is 2.16 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hemant Surgical Industries's current PB Ratio is 3.51, which is near median its own 10-year median of 3.65. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hemant Surgical Industries stock overvalued right now?
Based on GuruFocus' analysis, Hemant Surgical Industries (BOM:543916) is currently considered Fairly Valued. The stock's GF Value™ is ₹338.27, compared to a current price of ₹370.95 — trading 9.7% above its estimated fair value. The current PB Ratio is 3.51, which is near median its 10-year median of 3.65 and 62.5% above the Medical Devices & Instruments industry median of 2.16. Hemant Surgical Industries' overall GF Score™ is 77/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Hemant Surgical Industries (BOM:543916), the current PB Ratio is 3.51 as of Aug. 29, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hemant Surgical Industries (BOM:543916) Overvalued in 2026?
Based on GuruFocus' analysis, Hemant Surgical Industries stock appears to be overvalued.
The current stock price of ₹370.95 is trading 9.7% above its estimated GF Value™ of ₹338.27.
GuruFocus considers Hemant Surgical Industries to be Fairly Valued.
Key valuation signals for BOM:543916:
PB Ratio: 3.51 (near median its 10-year median of 3.65)
GF Value™: ₹338.27 vs. price of ₹370.95 (9.7% above fair value)
Industry Position: 62.5% above the Medical Devices & Instruments median (#543 of 783)
No single metric tells the full story. See the BOM:543916 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hemant Surgical Industries Ltd is engaged in Importing, manufacturing, and marketing quality surgical and Pharmaceutical Products at an economical price. Its product offerings cover a wide spectrum of equipment and disposables required for (i) Renal Care, (ii) Cardiovascular Disease, (iii) Respiratory Disease, (iv) Critical Care and Radiology, and (v) Surgical disposables. Its products include JMS Meditape, JMS Infusion Set, JMS Scalp Vein Set, Ventilators, ECG Machines, and others.
77GF Score
Get the complete analysis for BOM:543916
PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543916 has been successfully added to your 
